课题基金 / 基金详情

PODOCYTE CELL LINEAGE IN GENITOURINARY DEVELOPMENT

PODOCYTE CELL LINEAGE IN GENITOURINARY DEVELOPMENT
泌尿生殖发育中的足细胞细胞谱系
批准号:
6381984
负责人:
SUSAN E. QUAGGIN
金额:
$10.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-30 至 2002-07-31

项目摘要

项目成果

SUSAN E. QUAGGIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (adapted from the application) The long-term goals of the applicant's research program will test the following two hypotheses: 1) that the podocyte (glomerular visceral epithelial cell) is required for glomerular angiogenesis during development and 2) that the podocyte is pivotal in progression of chronic renal dysfunction due to a variety of underlying causes that include diabetes, aging and inflammation. The promoter of a podocyte-specific gene, nephrin, has been cloned. A transgene containing 1.25-kb of the 5' flanking region of the human nephrin gene recapitulates the endogenous expression of the nephrin mRNA transcript, and is only expressed in podocytes in capillary-loop and mature stage glomeruli of the developing murine kidney. The proposed studies will use this promoter to generate novel reagents to delineate the role of the podocyte in kidney development and disease. The main objective of the present application is to develop mouse model systems to manipulate podocyte gene expression in vitro and in vivo. The Specific Aims include: 1. To generate a podocyte-specific Cre-recombinase mouse line in order to delete and over-express genes in a cell-specific manner during renal development. 2. To generate mouse founder lines that can be used to modify gene activity in an inducible manner in podocytes. 3. To isolate novel murine podocyte cell lines that expresses a "living" marker of differentiation. 4. To further characterize the cis-acting elements within the 1.25-kb podocyte-specific promoter of the nephrin gene in order to identify trans-acting factors that are responsible for podocyte-specific expression. 5. To generate a podocyte-specific knockout of vascular endothelial growth factor (VEGF). The reagents generated in the present application will allow both temporal and spatial modification of gene activity specifically in podocytes. It will be possible to manipulate candidate genes involved in glomerular angiogenesis and to determine the role of the podocyte in setting up the glomerular filtration barrier. In future studies, these reagents will be useful to determine the role of the podocyte in glomerulosclerosis and ultimately, to identify therapeutic targets for chronic renal disease.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1172/jci17423
发表时间: 2003-03
期刊: The Journal of clinical investigation
影响因子: --
作者: [V. Eremina;M. Sood;J. Haigh;A. Nagy;G. Lajoie;N. Ferrara;H. Gerber;Y. Kikkawa;J. Miner;]
通讯作者: V. Eremina;M. Sood;J. Haigh;A. Nagy;G. Lajoie;N. Ferrara;H. Gerber;Y. Kikkawa;J. Miner;
Administrative Core
Administrative Core
Administrative Core
NUKIDs: Scientist Training Program in Kidney Disease
国内基金
海外基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
  • 批准号:
    61602201
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2016
  • 负责人:
    周雄辉
  • 依托单位:
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
  • 批准号:
    81170309
  • 项目类别:
    面上项目
  • 资助金额:
    50.0万元
  • 批准年份:
    2011
  • 负责人:
    颜桥
  • 依托单位:
非小细胞肺癌Biomarker的Imaging MS研究新方法
  • 批准号:
    30672394
  • 项目类别:
    面上项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2006
  • 负责人:
    陆豪杰
  • 依托单位: